Xingan Wu

995 total citations
50 papers, 716 citations indexed

About

Xingan Wu is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Xingan Wu has authored 50 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 13 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Xingan Wu's work include Viral Infections and Vectors (25 papers), Viral Infections and Outbreaks Research (19 papers) and Vector-Borne Animal Diseases (9 papers). Xingan Wu is often cited by papers focused on Viral Infections and Vectors (25 papers), Viral Infections and Outbreaks Research (19 papers) and Vector-Borne Animal Diseases (9 papers). Xingan Wu collaborates with scholars based in China, United States and Uganda. Xingan Wu's co-authors include Fanglin Zhang, Zhikai Xu, Ziyu Liu, Hongwei Ma, Wei Ye, Linfeng Cheng, Yu Lan, Yingfeng Lei, Rongrong Liu and Fang Wang and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Xingan Wu

49 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingan Wu China	15	372	242	139	136	130	50	716
Gregorio Pérez‐Cordón Spain	15	247 0.7×	184 0.8×	37 0.3×	168 1.2×	82 0.6×	28	679
Nadia Storm United States	18	502 1.3×	217 0.9×	21 0.2×	48 0.4×	115 0.9×	29	1000
Hongxia Wu China	19	149 0.4×	243 1.0×	109 0.8×	192 1.4×	48 0.4×	57	781
Aleš Macela Czechia	18	221 0.6×	632 2.6×	68 0.5×	209 1.5×	40 0.3×	65	1.1k
Feng Zhu China	18	379 1.0×	255 1.1×	34 0.2×	173 1.3×	45 0.3×	59	938
Richard A. Winegar United States	20	195 0.5×	647 2.7×	308 2.2×	63 0.5×	179 1.4×	38	1.2k
Dieter Gerlach Germany	18	329 0.9×	340 1.4×	69 0.5×	171 1.3×	394 3.0×	44	964
Carla Weisend United States	14	455 1.2×	226 0.9×	22 0.2×	161 1.2×	154 1.2×	20	831
Lin Zhan China	15	133 0.4×	261 1.1×	81 0.6×	138 1.0×	51 0.4×	38	791
Chelsea Pinkham United States	16	319 0.9×	189 0.8×	11 0.1×	63 0.5×	240 1.8×	24	581

Countries citing papers authored by Xingan Wu

Since Specialization

Citations

This map shows the geographic impact of Xingan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingan Wu more than expected).

Fields of papers citing papers by Xingan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingan Wu. The network helps show where Xingan Wu may publish in the future.

Co-authorship network of co-authors of Xingan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingan Wu. A scholar is included among the top collaborators of Xingan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingan Wu. Xingan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaoxiao, Junmei Zhang, Yuhang Dong, et al.. (2025). Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein. Antiviral Research. 237. 106124–106124.

Zhang, Xiaoxiao, Shengzheng Wang, Junmei Zhang, et al.. (2025). A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX. Journal of Medical Virology. 97(2). e70182–e70182. 1 indexed citations

Liu, Rongrong, Gaomei Zhao, Honglei Li, et al.. (2025). Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning. eLife. 13. 5 indexed citations

Zhang, Bo, et al.. (2024). Acacetin Attenuates Sepsis-induced Acute Lung Injury via NLRC3-NF-κB Pathway. Inflammation. 48(1). 75–88. 3 indexed citations

Zhang, Junmei, et al.. (2024). Guanylate‐binding protein 1 inhibits Hantaan virus infection by restricting virus entry. Journal of Medical Virology. 96(6). e29730–e29730. 3 indexed citations

Liu, Rongrong, Wenjie Sun, Min Li, et al.. (2023). Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV. Virus Research. 334. 199149–199149. 2 indexed citations

Wang, Fang, Yongsheng Liu, Xiaoxiao Zhang, et al.. (2021). Coumarin Derivative N6 as a Novel anti-hantavirus Infection Agent Targeting AKT. Frontiers in Pharmacology. 12. 745646–745646. 9 indexed citations

Liu, Rongrong, Ziyu Liu, Haifeng Hu, et al.. (2021). HTNV infection of CD8+ T cells is associated with disease progression in HFRS patients. Communications Biology. 4(1). 652–652. 13 indexed citations

Zhang, Xiaoxiao, Ziyu Liu, Wenjie Sun, et al.. (2021). Nlrc3 Knockout Mice Showed Renal Pathological Changes After HTNV Infection. Frontiers in Immunology. 12. 692509–692509. 13 indexed citations

10.

Lei, Yingfeng, Pan Yang, Qiang Gao, et al.. (2018). Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies. Nature Microbiology. 3(3). 287–294. 39 indexed citations

11.

Kang, Jian, Lifei Wang, Yanhui Xu, et al.. (2018). Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes. Microbial Pathogenesis. 125. 84–92. 12 indexed citations

12.

Zhang, Xiaoxiao, et al.. (2018). Development of a Simple and Cost-Effective Method Based on T7 Endonuclease Cleavage for Detection of Single Nucleotide Polymorphisms. Genetic Testing and Molecular Biomarkers. 22(12). 719–723. 2 indexed citations

13.

Ma, Hongwei, Wei Ye, Tiejian Nie, et al.. (2017). In-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers. Frontiers in Cellular and Infection Microbiology. 7. 269–269. 23 indexed citations

14.

Ma, Ruixue, Linfeng Cheng, Xiaoxiao Zhang, et al.. (2016). Screening and Identification of an H-2Kb-Restricted CTL Epitope within the Glycoprotein of Hantaan Virus. Frontiers in Cellular and Infection Microbiology. 6. 151–151. 9 indexed citations

15.

Liu, Ziyu, Fang Wang, Lijuan Yuan, et al.. (2016). Development of a SYBR-Green I quantitative PCR assay for the detection and genotyping of different hantaviruses. International Journal of Molecular Medicine. 38(3). 951–960. 3 indexed citations

16.

Yin, Jikai, Lijuan Yuan, Ziyu Liu, et al.. (2014). Recombinant fusion proteins FPTD-Grb2-SH2 and FPTD-Grb2-SH2M inhibit the proliferation of breast cancer cells in vitro. Oncology Reports. 31(6). 2669–2675. 1 indexed citations

17.

Liu, Ziyu, Xingan Wu, Fanglin Zhang, et al.. (2013). AhR expression is increased in hepatocellular carcinoma. Journal of Molecular Histology. 44(4). 455–461. 47 indexed citations

18.

Jiang, Xu, et al.. (2009). An improved method for refolding recombinant decay accelerating factor for therapeutic studies. Protein Expression and Purification. 66(1). 102–106. 1 indexed citations

19.

Zhang, Fanglin, Xingan Wu, Yong Liu, et al.. (2007). The expression and genetic immunization of chimeric fragment of Hantaan virus M and S segments. Biochemical and Biophysical Research Communications. 354(4). 858–863. 14 indexed citations

20.

Zhang, Fanglin, Yong Liu, Yu Lan, et al.. (2004). Construction and identification of recombinant adenovirus containing chimeric gene G1S0.7 of Hantaan virus. The Journal of Immunology. 22(12). 1057–1060. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact